Mereo BioPharma Group plc is listed on the AIM market of the London Stock Exchange (LSE).
The stock symbol for Mereo BioPharma Group plc is AIM: MPH.
The group aims to leverage Mereo’s innovative business model and resources to develop novel medicines for patients and to become a leader in specialty biopharma.
Mereo is focused on the development of innovative medicines that aim to address unmet medical needs in rare and specialty disease areas and improve patient quality of life.
Mereo will seek to selectively acquire clinical-stage product candidates with demonstrated clinically meaningful data from large pharmaceutical companies and to further develop these product candidates to subsequent key value inflection points or to commercialisation. By selectively acquiring and further developing promising product candidates, the Group and its stakeholders can jointly participate in the value realisation through any future sale, licensing or commercialisation of the product candidate.
We are not authorised under the Financial Services and Markets Act 2000 to provide advice to investors. For investment advice, please contact a stockbroker or independent financial adviser regulated by the Financial Conduct Authority.
The Company’s Registrars are Capita Asset Services. Contact them on 0871 664 0300 (calls cost 10p per minute plus network extras, lines are open 9.00am-5.30pm Mon-Fri) from the UK and +44 20 8639 3399 from outside the UK. Alternatively you could email them at email@example.com, or write to:
Capita Asset Services
34 Beckenham Road
Kent BR3 4TU
Contact Capita Registrars direct if your query relates to:
- change of name or address
- lost or stolen share certificate
- death of the registered holder of the shares
The Registrars keep a record of your name, address and the number of shares you own and can arrange to issue a duplicate certificate if necessary. If you have lost a certificate please report this to the Registrars as soon as possible on 0871 664 0300 from the UK or +44 208 639 3399 from overseas so they can put a “stop” on that certificate.
For more information, please visit the Shareholder Portal Section of the Registrars website.
When you change address, it is important you inform the Registrars as soon as possible to ensure you receive all shareholder communications. You can do this on-line at the Shareholder Portal Section of the Registrars website. Alternatively you can send a letter to the Registrars, which should include:
- your name in full, as shown on your share certificates
- your previous address
- your new address, your shareholder account number if you have one (this can be found on your share certificate)
- NB: All correspondence must be signed.
- For security reasons, the Registrars cannot accept address changes by e-mail and can only accept address changes over the telephone if the shareholder is able to clear certain security procedures.
You can do this via the Shareholder Portal Section of the Registrars website and download the relevant forms. Alternatively you can write to the Registrars giving full details of the following:
- your old name
- your new name
- a copy of any legal documentation, such as marriage certificate or deed poll
- where your name has changed as a result of separation or divorce, and you wish to revert to your maiden name, a copy of any supporting documentation must be sent to the Registrars
- NB: All correspondence must be signed
To buy more shares or sell shares you already own, you must use a stockbroker. The London Stock Exchange provides a page on their website dedicated to assisting private investors find a broker. For more information, please visit the London Stock Exchange website (under their Prices/Markets tab). Alternatively our Registrars also offer an on-line and telephone share dealing service and they can be contacted on 0871 664 0364 or at the Capita Deal website.
Never miss an update from Mereo. Sign up for and select the type of alerts you would like to receive by email.Register for Email Alerts
Share Price Information
Mereo is a specialty biopharma company developing innovative medicines for patients. Find out about our share price and latest trades.View Share Price